Range Resources (NYSE:RRC) reported quarterly earnings of $1.37 per share which met the analyst consensus estimate. This is a 163.46 percent increase over earnings of $0.52 per share from the same period last year. The company reported quarterly sales of $1.10 billion which beat the analyst consensus estimate of $1.02 billion by 7.84 percent. This is a 38.29 percent increase over sales of $795.40 million the same period last year.
CymaBay Therapeutics Deal May Not Be Needle Moving For $100B Valued Gilead, But Acquisition Is Reasonably Priced: Analyst
Gilead's acquisition of CymaBay Therapeutics for $4.3 billion strengthens its liver disease portfolio. Analysts see potential in seladelpar's impact on PBC and pruritus, projecting peak sales of $800 million.
